Gynesonics
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$42.5M
Gynesonics develops minimally invasive solutions for symptomatic uterine fibroids, with their flagship product being the Sonata System®.
Focus Areas
Healthcare
Minimally Invasive Solutions
Uterine Fibroids Treatment
Medical Device Development
Intrauterine Imaging
Transcervical Treatment
Investors
